Technical Analysis for PYPD - PolyPid Ltd.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 3.38 | -3.02% | -0.11 |
PYPD closed down 3.06 percent on Wednesday, November 20, 2024, on 7.06 times normal volume. It was able to find support at its 50 day moving average. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Bearish Engulfing | Bearish | -3.02% | |
| 20 DMA Support | Bullish | -3.02% | |
| 50 DMA Support | Bullish | -3.02% | |
| Hammer Candlestick | Bullish | -3.02% | |
| Volume Surge | Other | -3.02% | |
| Lower Bollinger Band Touch | Weakness | -3.02% | |
| Pocket Pivot | Bullish Swing Setup | -5.98% | |
| Narrow Range Bar | Range Contraction | -5.98% | |
| Gapped Up | Strength | -5.98% | |
| 50 DMA Support | Bullish | -2.26% |
| Alert | Time |
|---|---|
| Down 3% | about 1 hour ago |
| Fell Below 50 DMA | about 1 hour ago |
| Down 2 % | about 1 hour ago |
| Down 1% | about 1 hour ago |
| Fell Below 20 DMA | about 1 hour ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/13/2024
PolyPid Ltd. develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix platform. Its products include D-PLEX, an antibiotic drug reservoir that is implanted during surgery to prevent and treat surgical site infections; D-PLEX100 for the prevention of post-abdominal surgery incisional infection; BONYPID-1000, an antibiotic eluting ß tri-calcium phosphate granule for bone related infections applications; and BONYPID500, an antibiotic eluting bone graft substitute that fills and reconstructs periodontal and oral/maxillofacial defects, while protecting from infections. PolyPid Ltd. was founded in 2008 and is headquartered in Petach Tikva, Israel.
Sector: Healthcare
Industry: Biotechnology
Keywords: Surgery Bone Phosphates Infection Antibiotics Lipid Polyp Incision Bone Grafting Surgical Site
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Surgery Bone Phosphates Infection Antibiotics Lipid Polyp Incision Bone Grafting Surgical Site
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 9.2 |
| 52 Week Low | 2.95 |
| Average Volume | 7,392 |
| 200-Day Moving Average | 4.24 |
| 50-Day Moving Average | 3.47 |
| 20-Day Moving Average | 3.43 |
| 10-Day Moving Average | 3.49 |
| Average True Range | 0.22 |
| RSI (14) | 51.22 |
| ADX | 17.29 |
| +DI | 16.29 |
| -DI | 30.76 |
| Chandelier Exit (Long, 3 ATRs) | 3.07 |
| Chandelier Exit (Short, 3 ATRs) | 3.79 |
| Upper Bollinger Bands | 3.63 |
| Lower Bollinger Band | 3.24 |
| Percent B (%b) | 0.64 |
| BandWidth | 11.37 |
| MACD Line | 0.02 |
| MACD Signal Line | 0.00 |
| MACD Histogram | 0.0166 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.05 | ||||
| Resistance 3 (R3) | 4.03 | 3.81 | 3.96 | ||
| Resistance 2 (R2) | 3.81 | 3.67 | 3.83 | 3.93 | |
| Resistance 1 (R1) | 3.65 | 3.58 | 3.55 | 3.68 | 3.90 |
| Pivot Point | 3.44 | 3.44 | 3.39 | 3.45 | 3.44 |
| Support 1 (S1) | 3.28 | 3.30 | 3.17 | 3.30 | 3.08 |
| Support 2 (S2) | 3.06 | 3.21 | 3.08 | 3.05 | |
| Support 3 (S3) | 2.90 | 3.06 | 3.02 | ||
| Support 4 (S4) | 2.93 |
